Company Email Format Management

Vaxinano

Biotechnology Research Loos, Nord, Fr 14 employees

Employees: 14
Contacts: 1
Emails: 1
Phones: 1

vaxinano.com LinkedIn Crunchbase

Vaxinano Overview

Headquarters: Loos, Nord, Fr
Website: vaxinano.com
Industry: Biotechnology Research
Employees: 14
Funding: 6.5M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology Nanotechnology Vaccine Animal Health Human Health

About Vaxinano

Vaxinano is a clinical-stage biotechnology company, developing a new generation of nasally administered vaccines that are more efficient and faster to deploy to combat infectious diseases and new pandemics. The vaccine is based on STELLAR-NP nanoparticles that confer highly stable, adjuvant-free solution for an effective and long-lasting response tot protect against the most difficult pathogens, such as parasites, viruses or bacteria...

Vaxinano Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage
Phone contacts: 1; 25.0% coverage

Vaxinano Org Chart

Sample employees and titles

Name	Title	Location	Contact
Nicolas Roberti	Partner in Vc Fund, in Charge of Life Science Investments	Wezembeek-oppem, Flemish Region, Belgium	Email Phone
Romain Magnez	R&D Laboratory Manager @ Vaxinano	Lille, Hauts-de-france, France	View
Didier Betbeder	Founder of Vaxinano, Inventor & Developer		View
Angelo Scuotto	Head of Vaccine Development & Bioproduction - Vaxinano		View